Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lyra Therapeutics Inc (NQ: LYRA )

5.450 +0.130 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 230,447
Open 5.400
Bid (Size) 5.400 (20)
Ask (Size) 5.450 (14)
Prev. Close 5.320
Today's Range 5.210 - 5.530
52wk Range 3.300 - 9.980
Shares Outstanding 31,825,055
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lyra Therapeutics's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, Lyra Therapeutics's (NASDAQ:LYRA) reported sales totaled $5.37 million. Despite a 48.51% increase in earnings, the company posted a loss of $7.01... 
Via Benzinga
Peak Sales Potential For This ENT-Focused Stock Is Under-Appreciated, Says Cantor
 
Via Benzinga

Performance

YTD
+16.45%
+16.45%
1 Month
-0.91%
-0.91%
3 Month
+22.20%
+22.20%
6 Month
+17.46%
+17.46%
1 Year
-36.77%
-36.77%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
Via Benzinga
Recap: Lyra Therapeutics Q1 Earnings
Via Benzinga
Lyra Therapeutics Stock Surges On Equity Raise Of $100M
Via Benzinga
90 Biggest Movers From Yesterday
Via Benzinga
7 Stocks to Watch for Major Insider Trading Clues
Via InvestorPlace
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
54 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Executives Buy More Than $32M Of 4 Stocks
Via Benzinga
51 Biggest Movers From Thursday
Via Benzinga
The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2%
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
28 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide
Via Benzinga
Top Penny Stocks Today: Why ATER, BFRI, NDRA, MDVL and LYRA Stocks Are Soaring Friday
Via InvestorPlace
Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Lyra Therapeutics Kickstarts LYR-210 Pivotal Program in Surgically Naïve Chronic Rhinosinusitis Patients
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.